2.73
price down icon16.00%   -0.52
after-market Dopo l'orario di chiusura: 2.61 -0.12 -4.40%
loading

Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie

pulisher
10:48 AM

Real time scanner hits for Cyclerion Therapeutics Inc. explainedInsider Buying & Free Verified High Yield Trade Plans - newser.com

10:48 AM
pulisher
Sep 24, 2025

Cyclerion Therapeutics’ Licence Move: Boost or Bust? - StocksToTrade

Sep 24, 2025
pulisher
Sep 24, 2025

Hengrui, Glenmark ink ADC deal; Rome Therapeutics to seek ‘strategic options’ - Endpoints News

Sep 24, 2025
pulisher
Sep 24, 2025

Why Is Cyclerion Stock Surging In Pre-market Trade? - Nasdaq

Sep 24, 2025
pulisher
Sep 24, 2025

Full technical analysis of Cyclerion Therapeutics Inc. stockPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com

Sep 24, 2025
pulisher
Sep 24, 2025

Cyclerion Therapeutics jumps on MIT deal to develop depression drug - TradingView

Sep 24, 2025
pulisher
Sep 23, 2025

Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today? - MSN

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion signs MIT license for treatment-resistant depression program By Investing.com - Investing.com Australia

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion signs MIT license for treatment-resistant depression program - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Announces Transformational Relaunch As A Neuropsychiatric Company - TradingView

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics Enters License Agreement With MIT to Relaunch as Neuropsychiatric Firm - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus - TipRanks

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics (CYCN) Secures MIT Licensing for Strategi - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics Announces Strategic Relaunch and Licensing Agreement with MIT to Address Treatment-Resistant Depression - Quiver Quantitative

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion stock soars after MIT licensing deal to relaunch company - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company - GlobeNewswire

Sep 23, 2025
pulisher
Sep 23, 2025

Insiders Rewarded With US$55k Addition To Investment As Cyclerion Therapeutics Stock Hits US$7.6m - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Best data tools to analyze Cyclerion Therapeutics Inc. stockWeekly Risk Report & Accurate Technical Buy Alerts - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Cyclerion Therapeutics Inc. stock volume spike explainedMarket Trend Review & Growth Focused Stock Reports - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

How to use a screener to detect Cyclerion Therapeutics Inc. breakoutsStock Surge & Momentum Based Trading Signals - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

What MACD signals say about Cyclerion Therapeutics Inc.Trend Reversal & Stepwise Trade Execution Plans - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Multi asset correlation models including Cyclerion Therapeutics Inc.July 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Quarterly Earnings: Is Cyclerion Therapeutics Incs growth already priced inShort Setup & Technical Pattern Alert System - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Using RSI to spot recovery in Cyclerion Therapeutics Inc.2025 Price Momentum & Short-Term Trading Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Cyclerion Therapeutics Inc. bounce back from current supportJuly 2025 Retail & Smart Allocation Stock Tips - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Strategies to average down on Cyclerion Therapeutics Inc.Inflation Watch & Target Return Focused Picks - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Exit strategy if you’re trapped in Cyclerion Therapeutics Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Update Recap: Can Cyclerion Therapeutics Inc deliver alphaJuly 2025 Momentum & Community Driven Trade Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Buyback Watch: Should I invest in Cyclerion Therapeutics Inc before earningsWeekly Market Outlook & AI Forecasted Entry/Exit Points - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Retail: Does Cyclerion Therapeutics Inc meet Warren Buffetts criteria2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Buyback Watch: Is Cyclerion Therapeutics Inc a good ESG investmentQuarterly Investment Review & Reliable Intraday Trade Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Is Cyclerion Therapeutics Inc stock a good pick for beginnersWeekly Profit Recap & Daily Price Action Insights - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Volume: Will Cyclerion Therapeutics Inc. benefit from geopolitical trends2025 Earnings Surprises & Low Risk Entry Point Tips - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Aug Volume: Is Cyclerion Therapeutics Inc stock a good pick for beginnersJuly 2025 Reactions & Verified Entry Point Detection - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Aug Rallies: What analysts say about Cyclerion Therapeutics Inc. stock2025 Momentum Check & Free High Accuracy Swing Entry Alerts - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Momentum Shift: What is the target price for Cyclerion Therapeutics Inc stockWeekly Investment Report & Free Fast Gain Swing Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Using economic indicators to assess Cyclerion Therapeutics Inc. potential2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Is this a good reentry point in Cyclerion Therapeutics Inc.Weekly Gains Report & AI Driven Price Forecasts - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Will Cyclerion Therapeutics Inc. price bounce be sustainableMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com

Sep 14, 2025
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):